FIELD: medicine, oncology, biochemistry. SUBSTANCE: invention proposes new methods for inhibition of activity NAALADase, methods for suppression of proliferation of tumor cells and methods for cancer treatment using inhibitors of NAALADase. Methods are characterized by using new medicinal agents - inhibitors of NAALADase that represent N-acetylated alpha-bound acid dipeptidase catabolizing N-acetylglutamate and N- acetylaspartate and glutamic acid. EFFECT: valuable medicinal properties of inhibitors, expanded assortment of agents of claimed designation. 73 cl, 6 dwg, 4 tbl, 65 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING GLUTAMATE DISORDERS | 1997 |
|
RU2211697C2 |
| DERIVATIVES OF PENTADICARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 1999 |
|
RU2268881C2 |
| 6,9-DISUBSTITUTED 2-[TRANS-(4-AMINOCYCLOHEXYL)-AMINO]PURINES | 1999 |
|
RU2191777C2 |
| N-REPLACED BENZOSULPHONAMIDES | 2004 |
|
RU2364587C2 |
| METHOD OF PREPARING CONDENSED INDOLES AND INDENES DERIVATIVES | 0 |
|
SU728716A3 |
| TETRAHYDROCARBOLINE DERIVATIVE | 2011 |
|
RU2572818C2 |
| DERIVATIVES OF AMINO ACID, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF SUPPRESSION OF MULTIDRUG RESISTANCE | 1995 |
|
RU2165410C2 |
| URAT1 INHIBITORS | 2015 |
|
RU2721844C2 |
| SPIROAZACYCLIC COMPOUNDS, METHOD FOR INHIBITION IF ACTIVITY OR ACTIVATION OF SEROTONIN 5-НТ2А RECEPTOR, METHOD FOR TREATMENT OF MORBID STATE ASSOCIATED WITH SEROTONIN 5-НТ2А RECEPTOR AND THEIR USING | 2002 |
|
RU2315051C2 |
| PYRIMIDINE DERIVATIVES WITH ANTAGONIST PROPERTIES TOWARDS CRTH2(VERSIONS) | 2004 |
|
RU2361865C2 |
